Benitec Biopharma Ltd ADR (BNTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 184,875 | 188,903 | 94,592 | 97,857 | 103,646 |
| Receivables | 3 | 130 | 7 | 33 | 3 |
| Other current assets | 1,139 | 562 | 480 | 628 | 361 |
| TOTAL | $186,017 | $189,595 | $95,079 | $98,518 | $104,010 |
| Non-Current Assets | |||||
| PPE Net | 116 | 115 | 118 | 131 | 145 |
| Investments And Advances | 55 | 55 | 55 | 55 | 55 |
| Other Non-Current Assets | 812 | 916 | 775 | 888 | 999 |
| TOTAL | $983 | $1,086 | $948 | $1,074 | $1,199 |
| Total Assets | $187,000 | $190,681 | $96,027 | $99,592 | $105,209 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,251 | 1,850 | 1,148 | 1,022 | 6,254 |
| TOTAL | $3,274 | $2,801 | $2,025 | $1,802 | $7,026 |
| Non-Current Liabilities | |||||
| TOTAL | $394 | $519 | $403 | $495 | $613 |
| Total Liabilities | $3,668 | $3,320 | $2,428 | $2,297 | $7,639 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 34,354 | 34,354 | 33,862 | 26,250 | 25,600 |
| Common Shares | 3 | 3 | 2 | 2 | 2 |
| Retained earnings | -260,913 | -248,978 | -237,141 | -228,176 | -212,029 |
| Other shareholders' equity | -952 | -883 | -750 | -839 | -716 |
| TOTAL | $183,332 | $187,361 | $93,599 | $97,295 | $97,570 |
| Total Liabilities And Equity | $187,000 | $190,681 | $96,027 | $99,592 | $105,209 |